Chen Chuan, Chen Dong-Ping, Gu Yan-Yan, Hu Liang-Hao, Wang Dan, Lin Jin-Huan, Li Zhao-Shen, Xu Jing, Wang Ge
Cancer Center, Research Institute of Surgery, Daping Hospital, Third Military Medical University, No. 10 Changjiang Zhi Rd, Chongqing, 400042, China.
Tumour Biol. 2015 Aug;36(8):6255-63. doi: 10.1007/s13277-015-3311-8. Epub 2015 Apr 2.
Vascular invasion is one of the most important prognostic factors for patients with hepatocellular carcinoma (HCC). The objective of the current, retrospective study was to determine the associations of ascites and hepatitis B viral factors (HBeAg and anti-HBe status and HBV DNA levels), as well as tumor-related factors (size, tumor number, grade, and location) with micro- or macroscopic vascular invasion in patients with HCC that developed as a result of hepatitis B virus (HBV)-related cirrhosis. A total of 336 consecutive patients were included. Potential factors associated with micro- or macroscopic vascular invasion were analyzed by logistic regression. Ascites were more commonly detected in patients with micro- or macroscopic vascular invasion, and the presence of ascites was independently associated with vascular invasion. Among patients with mild-to-moderate or severe ascites, the odds ratio for macroscopic vascular invasion was 4.83 (95 % confidence interval [CI] 2.29-10.16) and 11.87 (95 % CI 4.53-31.07), respectively. Similarly, the presence of ascites was associated with microscopic vascular invasion (OR 5.00; 95 % CI 1.23-20.31). In contrast, hepatitis B viral factors were not significantly associated with vascular invasion. The presence of ascites was associated with vascular invasion in patients with HBV-related cirrhotic HCC. Thus, patients with ascites, vascular invasion should be considered and more frequent surveillance should be performed after curative treatment.
血管侵犯是肝细胞癌(HCC)患者最重要的预后因素之一。本项回顾性研究的目的是确定腹水和乙型肝炎病毒因素(HBeAg和抗-HBe状态以及HBV DNA水平),以及肿瘤相关因素(大小、肿瘤数量、分级和位置)与因乙型肝炎病毒(HBV)相关肝硬化而发生的HCC患者微血管或大血管侵犯之间的关联。总共纳入了336例连续患者。通过逻辑回归分析与微血管或大血管侵犯相关的潜在因素。微血管或大血管侵犯患者中更常检测到腹水,并且腹水的存在与血管侵犯独立相关。在轻度至中度或重度腹水患者中,大血管侵犯的比值比分别为4.83(95%置信区间[CI]2.29-10.16)和11.87(95%CI 4.53-31.07)。同样,腹水的存在与微血管侵犯相关(比值比5.00;95%CI 1.23-20.31)。相比之下,乙型肝炎病毒因素与血管侵犯无显著关联。腹水的存在与HBV相关肝硬化HCC患者的血管侵犯有关。因此,对于有腹水、血管侵犯的患者应予以考虑,并在根治性治疗后进行更频繁的监测。